Skip to main
NHP

NHP Stock Forecast & Price Target

NHP Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

National Healthcare is strategically positioning themselves for growth by focusing on their SHOP segment and divesting non-core assets, leading to an increased price target of $17/share. With potential growth in SHOP NOI and a focus on improving AFFO through increased target multiple and balance sheet improvements, the company plans to fund future investments through MOB sales, OP units, and retained cash flow. However, potential risks such as market conditions and sustainability should be monitored closely, while the company plans to achieve 100% SHOP exposure in the future, which is expected to drive accelerated earnings and a target price of $18/share.

Bears say

National Healthcare is a healthcare REIT that underwent a strategic shift in 2023 to focus solely on the senior housing and outpatient medical facility sectors, and therefore has a limited growth profile compared to its previous diversification. Due to this underwhelming potential for future growth, coupled with risks related to market conditions, consumer preferences, and regulatory trends, as well as the potential for damage to properties from severe weather events and insurance limitations, the negative outlook on National Healthcare's stock remains.

NHP has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Healthcare Properties and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Healthcare Properties (NHP) Forecast

Analysts have given NHP a Buy based on their latest research and market trends.

According to 7 analysts, NHP has a Buy consensus rating as of Sep 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Healthcare Properties (NHP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.